Profusa logo
Profusa
PFSA | NASDAQ
Chart Builder DCF Calculator
$0.45
-$0.10 (-18.18%)
At close: Nov 12, 2026, 3:59 PM ET
$0.46
+$0.01 (+1.47%)
After-hours: Nov 12, 2026, 7:52 PM ET

Profusa Company Profile

Company profile explained

Company Profile

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Key Executives

Name Position
Jack E. Stover Chief Executive Officer & Chairman
Fred S. Knechtel Chief Financial Officer
Chung-Bin Hwang President
David Icke Head of Digital Health Business
Sean Givens Head of Government Business
William McMillan Co-founder, Chief Scientific Officer & Head of Research

Latest SEC Filings

Date Type Title
Oct 27, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
View All SEC Filings ➞
Profusa
Profusa logo
Country United States
IPO Date Jul 14, 2025
Industry Medical - Devices
Sector Healthcare
Employees 2
CEO Jack E. Stover

Contact Details

626 Bancroft Way, Suite A Berkeley, California 94710 United States

Stock Details

Ticker Symbol PFSA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001859807
CUSIP Number 74319X405
ISIN Number US74319X4051
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.